[SCHEDULE 13G/A (AMENDMENT N0. 2) JinkoSolar Holding Co., Ltd. (Name of Issuer) American Depository Shares (Title of Class of Securities) 47759T100 (CUSIP Number) February 5, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) 1 see Notes CUSIP]
[SCHEDULE 13G/A (AMENDMENT N0. 2) JinkoSolar Holding Co., Ltd. (Name of Issuer) American Depository Shares (Title of Class of Securities) 47759T100 (CUSIP Number) February 5, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) 1 see Notes CUSIP]
[JinkoSolar Announces Pricing of Follow-on Offering of 3,600,000 American Depositary Shares and US$35 Million Concurrent Private Placement SHANGHAI, China, February 7, 2018 — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the "Company") (NYSE: JKS), a global leader in the solar PV industry, today anno]
[JinkoSolar Announces Pricing of Follow-on Offering of 3,600,000 American Depositary Shares and US$35 Million Concurrent Private Placement SHANGHAI, China, February 7, 2018 — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the "Company") (NYSE: JKS), a global leader in the solar PV industry, today anno]
[Silicon Motion Announces Results for the Period Ended December 31, 2017 NEWS RELEASE Financial Highlights 4Q 2017 GAAP 4Q 2017 Non-GAAP Net sales % Q/Q, -6% Y/Y $136.2 million (+7 % Q/Q, -6% Y/Y $136.2 million (+7 Gross margin 46.5% 46.6% Operating margin 10.0% 24.1% Earnings per diluted ADS]
[Silicon Motion Announces Results for the Period Ended December 31, 2017 NEWS RELEASE Financial Highlights 4Q 2017 GAAP 4Q 2017 Non-GAAP Net sales % Q/Q, -6% Y/Y $136.2 million (+7 % Q/Q, -6% Y/Y $136.2 million (+7 Gross margin 46.5% 46.6% Operating margin 10.0% 24.1% Earnings per diluted ADS]
[Sinovac Holds 2017 Annual General Meeting of Shareholders BEIJING, February 7, 2018 / PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it held its 2017 Annual General Meeting of Shareholder]
[Sinovac Holds 2017 Annual General Meeting of Shareholders BEIJING, February 7, 2018 / PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it held its 2017 Annual General Meeting of Shareholder]
